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Abstract 
One of complications in diabetes mellitus which occurs in the foot, due to a combination of peripheral 
vasculopathy, neuropathy and abnormal foot pressure, followed by immunopathy and infections is diabetic foot 
ulcer [1,2]. Those are a major medical, social, and economic problem and are the leading cause of 
hospitalization for patients with diabetes. Severe infections can lead to amputations and increasing the burden 
both to the patient and the hospital2. This study aims to know the microbiology pattern and the antibiotic 
sensitivity pattern for diabetic diabetic foot ulcer in Sardjito General Hospital. The data were obtained from 
Clinical Pathology Laboratory Sardjito Hospital. Subject in this study were diabetic foot ulcer patients whom 
hospitalized and undergo surgical procedure between January 2013, until January 2015. Foot ulcers samples 
acquired from wound bed during surgery were analyzed microbiologically to provide information about the 
bacterial pattern and their antibiotic sensitivity. From 64 patient samples analyzed, 27 different kind of bacteria 
were obtained. Acinetobacter baumanii was the most frequent bacteria isolated from patient in this study (25%), 
followed by Enterococcus faecalis (8%) and pseudomonas aeruginosa (8%).  The antibiotic sensitivity test was 
performed using 31 antibiotics, and the result was tabulated. Infection with multi drug resistant bacteria is 
common in diabetic foot ulcers and is associated with increased requirement for surgical treatment. This study 
proved that multidrug resistant bacteria also a complicating factor in Sardjito Hospital. There is a need for 
continuous surveillance of bacteria involved in diabetic foot infections to help determine the choice of suitable 
antibiotic selection. 
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1. Introduction 
Diabetes define as a group of metabolic diseases characterized by hyperglycemia resulting from defects in 
insulin secretion and insulin action, or either one [3]. This condition is a chronic progressive condition that will 
lead to a long-term damage, dysfunction, and failure of different organs, especially the eyes, kidneys, nerves, 
heart, and blood vessels. The diabetic foot ulcers progression will be faster if this condition left untreated 
(uncontrolled glucose level) [4]. The diagnosis criteria for diabetes mellitus including (1) HbA1C ≥ 6.5%, (2) 
Fasting plasma glucose ≥ 126 mg/dl, (3) 2-h plasma glucose ≥ 200 mg/dl during an OGTT, (4) In a patient with 
classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose ≥ 200 mg/dl [3]. 
Foot ulcer is one of diabetes complication [1,2,3,4]. This condition happens due to combination of peripheral 
neuropathy, peripheral vascular disease and impaired resistance, followed by infection [1,2]. Immunopathy also 
affect the patient’s resistance to infection [1]. Recent studies showing that lifetime risk of developing a foot 
ulcer in diabetic patient may be as high as 15% [5]. Foot ulcer is a very devastating and major cause of disability 
in patient with diabetes mellitus. This untreated condition will lead to gangrene, and subsequent lower limb 
amputation. Approximately 38% of diabetes patient in United States undergo amputation due to diabetic foot 
infection [6]. 
In treating diabetic foot ulcer, antimicrobial therapy is crucial. Choosing the right antibiotic for the specific 
bacteria is the key, but usually the therapy initiate with empirical measure before the bacterial culture and 
antibiotic sensitivity is available. Therefore, to find the appropriate empirical antibiotic therapy, it has to be 
studied for each region considering there might be difference in bacterial pattern in each region [7]. This study 
will identify the most common bacteria that causes infection in diabetic foot ulcer patient in Sardjito General 
Hospital and the antibiotic appropriate to eradicate the bacteria.  
2. Materials and Methods 
This is an observational study with cross sectional design. The data were obtained from Clinical Pathology 
Laboratory Sardjito Hospital. Subject in this study were diabetic foot ulcer patients whom hospitalized and 
undergo surgical procedure between January 2013 until January 2015. Foot ulcers samples taken from the 
wound bed during surgery were analyzed microbiologically to provide information about the bacterial pattern 
and their antibiotic sensitivity. 
3. Results and Discussion 
There are 64 patients undergo surgery procedure for diabetic ulcers between January 2013 until January 2015. 
Polymicrobial infection found in 21 patients (32,8%), 38 patients (59,36%) has monomicrobial infection, and 5 
patient (7,8%) has negative result (no growth) in microbial study. Sekhar and his colleagues in his study found 
from 108 specimens of the diabetic foot lesions, culture showed polymicrobial growth in 44.4% (48/108), 
monomicrobial growth in 44.4% (48/108), and no growth in 11.1% (12/108) [10]. While Lipsky and his 
colleagues in his study found higher incidence of polymicrobial infection compared to monomicrobial infection 
[11]. Result from this study is get along with study conducted by Singh and his colleagues in 2012, in which 
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monomicrobial infections cases (43.5%) were more than polymicrobial infections (35.5%) [12]. 
Table 1: Bacterial pattern in infection of diabetic foot ulcer in Sardjito General Hospital 
No Bacteria Patient infected 
1 Acinetobacter baumanii 23 
2 Burkholderia cepacia 2 
3 Candida albicans 1 
4 Citrobacter freundii 2 
5 Coagulase negative staphylococcus 2 
6 Entamoeba colii 2 
7 Enterobacter aerogenes 1 
8 Enterobacter cloacae 3 
9 Enterococcus faecalis 7 
10 Eschericia coli 4 
11 Klebsiella oxytosa 1 
12 Klebsiella pneumonia 8 
13 Kocuria kristinae 2 
14 Morganella morganii 1 
15 Proteus mirabillis 4 
16 Proteus vulgaris 2 
17 Providentia stuartii 2 
18 Pseudomonas aeruginosa 9 
19 Pseudomonas maltophilia 1 
20 Pseudomonas putida 1 
21 Staphylococcus aureus 3 
22 Staphylococcus epidermidis 2 
23 Staphylococcus haemolyticus 1 
24 Staphylococcus hom hominis 1 
25 Staphylococcus saprohiticus 1 
26 Streptococcus faecalis 2 
27 Streptococcus viridans 3 
28 Negatif result 5 
 
In this study, 27 different kind of bacteria were obtained from the samples (Table 1). Acinetobacter baumanii 
was the most frequent bacteria isolated from patient in this study (25,3%), followed by Pseudomonas 
aeroginosa (9,9%), Klebsiella pneumonie (8,8%) and Enterococcus faecalis (7,7%).  The antibiotic sensitivity 
test was performed using 31 antibiotics, and the result was tabulated for the 4 most common causing bacteria 
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(Table 2). 
Table 2: Antibiotic sensitivity for the 4 most common bacteria in diabetic foot ulcer in Sardjito General 
Hospital 
No Bacteria Most Sensitive Antibiotic 
1 
Acinetobacter 
baumanii 
Tigecycline 
(100%) 
Tetracycline 
(82%) 
Amikacin 
(73%) 
Meropenem 
(71%) 
Cefotaxime 
(67%) 
Cefuroxime 
(67%) 
2 
Pseudomonas 
Aeroginosa 
Gentamicin 
(100%) 
Levofloxacin 
(100%) 
Amikacin 
(100%) 
Meropenem 
(100%) 
Cefotaxime 
(100%) 
Ciprofloxacin 
(86%) 
3 
Klebsiella 
pneumoniae 
Cefmetazole 
(100%) 
Tetracycline 
(100%) 
Amikacin 
(100%) 
Meropenem 
(100%) 
Tigecycline 
(75%) 
Cefepime 
(75%) 
4 
Enterococcus 
faecalis 
Co-
Amoksiclav 
(100%) 
Tigecycline 
(100%) 
Linezolid 
(100%) 
Ampicilin-
Sulbactam 
(100%) 
Piperacilin 
(100%) 
Vancomycin 
(100%) 
 
A study in 530 patients with diabetic foot infection conducted by Mathangi T, it was shown that Staphylococcus 
aureus (21,6%) is the most common bacteria isolated, followed by Pseudomonas aeruginosa (15,1%) and 
Escherichia coli (14%) [2]. Jabbar and his colleagues in his study in Southern India shows that Staphylococcus 
aureus (21.8%), Enterococcus faecalis (4.6%), Pseudomonas aeruginosa (18.2%), Escherichia coli (13.6%), 
Proteus spp (9.1%), and Acinetobacter baumannii (7.3%), Klebsiella pneumoniae (6.4%) found from 110 
samples of 75 patients [13]. Cardoso and his colleagues found Pseudomonas, Proteus, and Morganella as the 
most common bacteria found in diabetic foot ulcer, with acinetobacter and klebsiella are the predictive factor for 
amputation in diabetic foot ulcer [14]. 
Acinetobacter baumannii is a Gram-negative bacillus that is aerobic, pleomorphic, non-motile, and also an 
opportunistic  human pathogen. In human body, A. Baumanii infection can implicate wide range of anatomical 
region, causing pneumonia, bloodstream infection, wound infection, and meningitis. Recent years, there is a 
dramatic increase in the incidence of multidrug-resistant (MDR) strains of this bacteria [12]. 
Infection is a common and serious complication of diabetic foot wounds. Infection will cause further ischemia, 
necrosis, progressive gangrene, and then will increase the need of amputation in diabetic foot ulcer patient. Foot 
ulcer in diabetic patient initiate from a local trauma and/or pressure (often in association with lack of sensation 
because of neuropathy). With the combination of microvascular disease, this condition may result in various 
diabetic foot infections that run the spectrum from simple, superficial cellulitis to acute and chronic 
osteomyelitis and deep-skin and soft-tissue infections [1]. 
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Multi-drug resistant pathogens in diabetic foot ulcer increasing risk of peripheral artery disease which could lead 
to amputation [8]. The increasing of multi-drug resistant (MDR) pathogens in diabetic foot ulcers is a challenge 
faced by the physician or the surgeon in treating diabetic ulcers without resorting to amputation. To prevent this 
MDR pathogens from getting increased, usage of antibiotics have to be appropriate.  
The most potent antibiotic in this study to inhibit Acinetobacter baumanii culture is Tigecycline with 100% 
sensitivity. While Gentamycin, Levofloxacin, Amikacin, Meropenem, and Cefotaxime proved success to inhibit 
the Pseudomonas aeruginosa isolate.  
Acinetobacter baumanii is a multi drug resistant bacteria with only few antibiotics active against it. Beta-lactam 
antibiotic is the first line choice in treatment of Acinetobacter baumanii infections. But in recent years due to 
resistance of the bacteria, carbapenem become the second line choice [16]. In this study, cefotaxime and 
cefuroxime (beta-lactam group antibiotics) each has 67% effectiveness against Acinetobacter baumanii, while 
meropenem (carbapenem group) has 71 % effectiveness. Effectiveness of tigecycline against Acinetobacter 
baumanii also desribed in Pachon-Ibanez study in 2004, which 92% of the A. baumannii strains were 
tigecycline susceptible [17]. Meta analisys by Wentao Ni and his colleagues Against the use of tigecycline 
because it is associated with higher in-hospital mortality, lower microbial eradication rate and longer hospital 
stay [18].  
Also showed in the result of this study, amikacin, cefmetazole, meropenem, and tetracycline are potent 
antibiotic to inhibit Klebsiella pneumonia cultures. amoxicillin/clavulanic acid, linezolid, piperacillin, 
ampicillin/sulbactam, tigecycline, piperacillin/tazobactam, and vancomycin, can 100% inhibit Enterococcus 
faecalis cultures 
4. Conclusion and Recommendations 
Acinetobacter baumanii is the most common type of microorganisms isolated from this study, followed by 
Pseudomonas aeruginosa, Klebsiella pneumonia, and Enterococcus faecalis . The most potent antibiotic in this 
study to eradicate Acinetobacter baumanii culture is Tigecycline with 100% sensitivity. Aside of that, 
Gentamycin, Levofloxacin, Amikacin, Meropenem, and Cefotaxime proved success to eradicate the 
Pseudomonas aeruginosa and Enterococcus faecalis isolate which is the second most common type of 
microorganisms isolated from this study. There is a need for continuous surveillance of bacteria involved in 
diabetic foot infections to help determine the choice of suitable antibiotic selection. Study for pathogen and 
antimicrobial sensitivity for diabetic foot ulcer should performed in each medical facilities, because of different 
pathogens and sensitivity of antibiotic in each locations. More study also need to determine the most potent 
antibiotic against each pathogen. The bacterial study and antimicrobial sensitivity study in diabetic foot ulcer is 
very important for more rational use of antibiotics. 
5. Limitation 
This study is only performed in diabetic foot ulcer patient which undergo surgery procedure. Although it was to 
get better samples for bacterial study, but we can not involve samples from diabetic foot ulcer patients which 
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treat conservatively. 
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